Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818642) titled 'Patient-Reported Outcomes Following Loose Seton Material Replacement in Complex Anal Fistula' on Sept. 6.

Study Type: Observational [Patient Registry]

Primary Sponsor: Acibadem Kent Hospital

Condition: Complex Anal Fistula Cryptoglandular Anal Fistula

Intervention: Device: Loose Seton Biomaterial

Recruitment Status: Not recruiting

Date of First Enrollment: October 1, 2026

Target Sample Size: 50

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07818642

Published by HT Digital Content Services with permission from Health Daily Digest....